| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |